Medibank Private Ltd
ASX:MPL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.41
4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Medibank Private Ltd
Medibank Private Ltd
Cash Equivalents
Medibank Private Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medibank Private Ltd
ASX:MPL
|
Cash Equivalents
AU$691m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Generation Development Group Ltd
ASX:GDG
|
Cash Equivalents
AU$259.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
NobleOak Life Ltd
ASX:NOL
|
Cash Equivalents
AU$64m
|
CAGR 3-Years
26%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
NIB Holdings Ltd
ASX:NHF
|
Cash Equivalents
AU$275.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
27%
|
|
Medibank Private Ltd
Glance View
Medibank Private Ltd., a cornerstone of Australia’s healthcare industry, found its origins as a government-run enterprise, established to provide affordable health insurance to Australians. Over the years, it has undergone a significant transformation, becoming a publicly listed company in 2014. Medibank’s journey reflects a broader narrative of innovation and adaptation within the health insurance sector. As one of the leading providers in Australia, it caters to both private individuals and corporate entities, offering a wide range of health insurance products that cover hospital and extras services. This diversification not only strengthens its revenue streams but also positions Medibank as a central player in a competitive market. At the heart of Medibank's business model lies a dual approach: robust health insurance offerings and a commitment to promoting well-being through preventive healthcare measures. The company generates revenue primarily by collecting premiums from policyholders, which are then used to pay out claims and cover operational costs. Beyond traditional insurance, Medibank has been proactive in investing in digital health platforms and partnerships, enhancing its service delivery with innovative health management programs. Through these initiatives, Medibank aims to reduce long-term healthcare costs by encouraging healthier lifestyles among its members, thereby sustaining its profitability and ensuring customer loyalty. This strategy underscores a keen understanding of the evolving healthcare landscape and a commitment to ensuring sustainable growth.
See Also
What is Medibank Private Ltd's Cash Equivalents?
Cash Equivalents
691m
AUD
Based on the financial report for Jun 30, 2024, Medibank Private Ltd's Cash Equivalents amounts to 691m AUD.
What is Medibank Private Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
1%
Over the last year, the Cash Equivalents growth was 64%. The average annual Cash Equivalents growth rates for Medibank Private Ltd have been 1% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
